• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Feasibility of Text Message Influenza Vaccine Safety Monitoring During Pregnancy

tetano

Editor, Senior Moderator
Am J Prev Med. 2017 May 2. pii: S0749-3797(17)30204-0. doi: 10.1016/j.amepre.2017.03.014. [Epub ahead of print]
[h=1]Feasibility of Text Message Influenza Vaccine Safety Monitoring During Pregnancy.[/h] Stockwell MS[SUP]1[/SUP], Cano M[SUP]2[/SUP], Jakob K[SUP]3[/SUP], Broder KR[SUP]2[/SUP], Gyamfi-Bannerman C[SUP]4[/SUP], Casta?o PM[SUP]4[/SUP], Lewis P[SUP]2[/SUP], Barrett A[SUP]3[/SUP], Museru OI[SUP]2[/SUP], Castellanos O[SUP]3[/SUP], LaRussa PS[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]INTRODUCTION:[/h] The feasibility and accuracy of text messaging to monitor events after influenza vaccination throughout pregnancy and the neonatal period has not been studied, but may be important for seasonal and pandemic influenza vaccines and future maternal vaccines.
[h=4]METHODS:[/h] This prospective observational study was conducted during 2013-2014 and analyzed in 2015-2016. Enrolled pregnant women receiving inactivated influenza vaccination at a gestational age <20 weeks were sent text messages intermittently through participant-reported pregnancy end to request fever, health events, and neonatal outcomes. Text message response rates, Day 0-2 fever (≥100.4?F), health events, and birth/neonatal outcomes were assessed.
[h=4]RESULTS:[/h] Most (80.2%, n=166) eligible women enrolled. Median gestational age was 8.9 (SD=3.9) weeks at vaccination. Response rates remained high (80.0%-95.2%). Only one Day 0-2 fever was reported. Women reported via text both pregnancy- and non-pregnancy-specific health events, not all associated with medical visits. Most pregnancy-specific events in the electronic medical record (EMR) were reported via text message. Of all enrollees, 84.9% completed the study (131 reported live birth, ten reported pregnancy loss). Two losses reported via text were not medically attended; there was one additional EMR-identified loss. Gestational age and weight at birth were similar between text message-reported and EMR-abstracted data and 95% CIs were overlapping for proportions of prematurity, low birth weight, small for gestational age, and major birth defects, as identified by text message-reported versus EMR-abstracted plus text message-reported versus EMR-abstracted data only.
[h=4]CONCLUSIONS:[/h] This study demonstrated the feasibility of text messaging for influenza vaccine safety surveillance sustained throughout pregnancy. In these women receiving inactivated influenza vaccination during pregnancy, post-vaccination fever was infrequent and a typical pattern of maternal and neonatal health outcomes was observed.
Copyright ? 2017 American Journal of Preventive Medicine. All rights reserved.


PMID: 28495223 DOI: 10.1016/j.amepre.2017.03.014
 
Back
Top Bottom